Cure My Disease

Don't miss your cure!

 Log in / Sign up

Sound waves vs. superbugs: can a simple ultrasound curb unnecessary antibiotics in kids?

NCT ID NCT06876766

Disease control Sponsor: American University of Beirut Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This study investigates whether using lung ultrasound (a safe, radiation-free imaging technique) can help doctors decide when to stop antibiotics in children and teens hospitalized with lower respiratory tract infections like pneumonia. Half of the participants will receive a lung ultrasound within 24 hours of admission to guide antibiotic decisions, while the other half will receive standard care. The goal is to see if ultrasound can safely reduce the number of children sent home with antibiotic prescriptions, helping to fight antibiotic resistance.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Lung ultrasound (device)
What this could lead to
If successful, this approach could help doctors safely reduce unnecessary antibiotic use in children with lung infections, lowering the risk of antibiotic resistance and side effects.
What could go wrong
This is a relatively small, early-stage trial, and the results may not apply to all hospitals or patient groups. The ultrasound might not always change prescribing decisions as expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 176 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2025

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

3 months to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 3 months and 17 years old inclusive * Currently admitted to the pediatric Ward or boarding in the Emergency Department within 24 hours of admission order due to lower respiratory tract infections. Exclusion Criteria: * Sickle cell disease (SCD). * On chemotherapy or any other immunosuppressive therapy except systemic corticosteroids use of ≤ 5 days duration. * Cystic fibrosis and other chronic lung diseases except asthma * Pre-existing and/or congenital neurologic, metabolic, and cardiac conditions * Hospitalized within the previous month * Patients with suspected foreign body aspiration -Received antibiotic therapy within the previous week * Patients admitted under PI's care

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lower resp tract infection are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lower respiratory tract disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lower resp tract infection

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • American University of Beirut Medical Center

    RECRUITING

    Beirut, 1107 2020, Lebanon

More trials for these conditions

Other studies related to the condition(s) this trial covers.